Abstract
The interconversion of carbon dioxide and the bicarbonate ion is carried out by carbonic anhydrases (CA), which are ubiquitous metalloenzymes with Zn in their active site. Disorder of CA enzymes can cause several diseases such as glaucoma, epilepsy, obesity, and cancer. Many existing drugs have shown effective inhibition of CAs including Acetazolamide, Dorzolamide, Methazolamide, and Valdecoxib. In order to conceive new agents inhibiting CAs, two small molecules were synthesized and characterized by the usual spectroscopic methods. The prepared compounds were obtained by the condensation of dimedone and cyclohexanedione with CSI (chlorosulfonyl isocyanate) in the presence of methanol as a proton donor. The synthesized derivatives contain a primary amide group (CONH2) bio-isostere of the sulfonamide group (SO2NH2) which is present in the quasi-totality of CAs inhibitors. The interactions between our new synthesized molecules and the active site of CAII were determined using docking simulation (PDB: 2AW1); the results showed great stability of these compounds inside the active site with the presence of metallic and hydrogen bonds similar to the ones present between CAII and the reference Valdecoxib. Pharmacokinetic properties and toxicity were predicted using in silico tool SwissADME and Molsoft.
Supplementary Materials
The following are available online at https://www.mdpi.com/article/10.3390/ECMC2022-13446/s1.
Author Contributions
Conceptualization, A.B.; methodology, A.B. and Y.O.B.; software, A.B.; validation, A.B., Y.O.B., R.M. and N.-E.A.; formal analysis, A.B.; investigation, A.B. and Y.O.B.; writing—original draft preparation, A.B.; writing—review and editing, A.B., Y.O.B., R.M., and N.-E.A. All authors have read and agreed to the published version of the manuscript.
Funding
This research received no external funding.
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Not applicable.
Conflicts of Interest
The authors declare no conflict of interest.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).